South Korea's SK Bioscience to buy stake in German vaccine firm IDT Biologika for $244 mln

SK Bioscience Co

27/06/2024 24:10

SEOUL, June 27 (Reuters) - South Korean vaccine maker SK
Bioscience  302440.KS  said in a regulatory filing on Thursday
it will acquire a controlling stake in German vaccine firm IDT
Biologika GmbH, as well as existing shares in another firm
called Technik-Energie-Wasser Servicegesellschaft mbH, for a
total of 339 billion won ($243.75 million). 
    

($1 = 1,390.7600 won)

 (Reporting by Joyce Lee; Editing by Kim Coghill)
 ((joyce.lee@tr.com;))